1. Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva. (15th May 2022) Authors: Ullrich, Thomas; Arista, Luca; Weiler, Sven; Teixeira-Fouchard, Sylvie; Broennimann, Valérie; Stiefl, Nikolaus; Head, Victoria; Kramer, Ina; Guth, Sabine Journal: Bioorganic & medicinal chemistry letters Issue: Volume 64(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗